Maybe it'll boost Volume n PPS -

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Prev Message Back To Forum Threaded View Next Message

emit

Rank: Vice President [?]

Points: 41186 [?]

Votes: 199 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Maybe it'll boost Volume n PPS -

posted on Jun 13, 2011 01:28PM

Shares of Pluristem Therapeutics to be Included in Mid Cap 50 TA Index on the Tel Aviv Stock Exchange (TASE) Beginning June 15, 2011

HAIFA, Israel, June 13, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI - News) (TASE:PLTR - News) today announced that according to the TASE announcement, its ordinary shares will be added to the Mid-Cap-50 Index on the TASE, beginning on June 15, 2011. The Mid-Cap-50 Index includes the 50 shares with the highest market capitalization that are not included in the TA-100 index.

Following the inclusion in the Mid-Cap-50 the company's ordinary shares will be included in the following TASE equity indexes: Biomed Index, Mid-Cap-50 TA Index, TA BlueTech-50 Index, TA Composite Index, Shares Index and the Industry Index.

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply